3/15/2017 Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I. PLoS One. 2017; 12(3):e0172864.
2/28/2017 Do primary care provider strategies improve patient participation in colorectal cancer screening? Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L. Am J Gastroenterol. 2017; 112(4):622-32. Epub 2017 Feb 28.
2/27/2017 A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive fecal occult blood test in Ontario’s ColonCancerCheck Program Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Curr Oncol. 2017; 24(1):47-51.